23 results
8-K
EX-99.1
ARCT
Arcturus Therapeutics Holdings Inc
13 Dec 22
Arcturus Appoints John Markels, Ph.D. to its Board of Directors
4:14pm
President of Global Vaccines at Merck, to provide strategic oversight to the Company’s vaccine franchise
San Diego, Calif., December 13, 2022 – Arcturus … , Dr. Markels will provide strategic oversight to the Company’s vaccine franchise and manufacturing processes.
“We are very pleased to welcome Dr
DEFR14A
jvdizx
12 May 22
Revised proxy
5:00pm
8-K
EX-14.1
vxv6fes0ogoo6m52c
13 Dec 21
Arcturus Therapeutics Appoints Jing Marantz, M.D., Ph.D., M.B.A. to its Board of Directors
5:17pm
8-K
EX-1.1
7jvi3a1kl23o f3kug7o
8 Dec 20
Arcturus Therapeutics Announces Pricing of $150 Million Public Offering of Common Stock
9:01am
8-K
EX-1.1
9obs5yiizlx jv
29 Jul 20
Arcturus Therapeutics Announces Pricing of $173.0 Million Public Offering of Common Stock
6:02am
8-K
EX-1.1
7ldx9r2 pw1fvmw6y1x
17 Apr 20
Entry into a Material Definitive Agreement
6:06am
8-K
EX-10.1
uz8ufsk3yvdnacopl51h
27 Mar 20
Entry into a Material Definitive Agreement
5:20pm
10-K
2091jvr2hg3rx
16 Mar 20
Annual report
11:09am
DEF 14A
i352i1o5rid
1 Oct 19
Definitive proxy
6:07am